Congenica offers a clinical genomic interpretation platform that transforms raw sequencing data into actionable clinical insights for rare disease, oncology, and infectious diseases. Born from the Wellcome Sanger Institute and now part of the SeqOne family, their AI-powered platform is trusted by over 190 labs in 35+ countries and supports national programs like Genomics England and the NHS. Congenica serves laboratories and clinicians by accelerating the delivery of personalized medicine at scale.